Why the study?
Venous thromboembolism in pregnancy is a major factor of maternal mortality, presenting challenges in distinguishing physiologic changes from symptoms and balancing the risks and benefits of anticoagulation.
Design
Review
Authors
Loading...
May guide anticoagulation decisions for pregnancy-associated VTE; leaves open need for prospective validation of strategies.
Systemic anticoagulation remains the cornerstone of VTE management in pregnancy, requiring careful balance of maternal and fetal risks.
Kalaitzopoulos et al. (2022) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: